- Home
- NUAI vs RPID Comparison
NUAI vs RPID Comparison
Compare NUAI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUAI | RPID |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 204.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NUAI | RPID |
|---|---|---|
| Price | $4.61 | $3.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 7.5M | 340.8K |
| Earning Date | 03-31-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $843,029.00 | ★ $30,523,000.00 |
| Revenue This Year | N/A | $19.91 |
| Revenue Next Year | N/A | $21.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.89 | 16.63 |
| 52 Week Low | $0.32 | $1.86 |
| 52 Week High | $9.45 | $4.94 |
Technical Indicators
Market Signals| Indicator | NUAI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 47.86 |
| Support Level | $4.78 | $3.66 |
| Resistance Level | $5.39 | $4.40 |
| Average True Range (ATR) | 1.00 | 0.40 |
| MACD | -0.30 | -0.06 |
| Stochastic Oscillator | 0.26 | 11.72 |
Price Performance
Historical ComparisonAbout NUAI New Era Energy & Digital Inc.
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.